Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose-escalation regimens of bosutinib treatment for patients with chronic myeloid leukemia - Mita, A; Abumiya, M; Miura, M (Exp Hematol Oncol, 2018)
et al.